bevacizumab
roche
['beva', 'bevacizumab']
the aim of this study is to describe the incidence and severity of joint manifestations among bevacizumab treated patients as well as their relation to clinical outcomes. read now as part of our #asco22 article collection 
Latest research and news from Elsevier Oncology journals. Publishing support: https://t.co/0zIQ5ZFYVL